These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12009233)

  • 1. Expression of peroxisome proliferator activated receptor-gamma in non-small cell lung carcinoma: correlation with histological type and grade.
    Theocharis S; Kanelli H; Politi E; Margeli A; Karkandaris C; Philippides T; Koutselinis A
    Lung Cancer; 2002 Jun; 36(3):249-55. PubMed ID: 12009233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival.
    Giaginis C; Politi E; Alexandrou P; Sfiniadakis J; Kouraklis G; Theocharis S
    Pathol Oncol Res; 2012 Oct; 18(4):875-83. PubMed ID: 22426809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of peroxisome proliferator-activated receptor-gamma in colon cancer: correlation with histopathological parameters, cell cycle-related molecules, and patients' survival.
    Theocharis S; Giaginis C; Parasi A; Margeli A; Kakisis J; Agapitos E; Kouraklis G
    Dig Dis Sci; 2007 Sep; 52(9):2305-11. PubMed ID: 17393321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer.
    Keshamouni VG; Reddy RC; Arenberg DA; Joel B; Thannickal VJ; Kalemkerian GP; Standiford TJ
    Oncogene; 2004 Jan; 23(1):100-8. PubMed ID: 14712215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of peroxisome proliferator-activated receptor (PPAR)-gamma in human lung cancer.
    Inoue K; Kawahito Y; Tsubouchi Y; Yamada R; Kohno M; Hosokawa Y; Katoh D; Bishop-Bailey D; Hla T; Sano H
    Anticancer Res; 2001; 21(4A):2471-6. PubMed ID: 11724309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells.
    Satoh T; Toyoda M; Hoshino H; Monden T; Yamada M; Shimizu H; Miyamoto K; Mori M
    Oncogene; 2002 Mar; 21(14):2171-80. PubMed ID: 11948400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-gamma activated by ligands can inhibit human lung cancer cell growth through induction of apoptosis.
    Zhang M; Zou P; Bai M; Jin Y; Tao X
    J Huazhong Univ Sci Technolog Med Sci; 2003; 23(2):138-40. PubMed ID: 12973930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator activated receptor-gamma ligands as potent antineoplastic agents.
    Theocharisa S; Margeli A; Kouraklis G
    Curr Med Chem Anticancer Agents; 2003 May; 3(3):239-51. PubMed ID: 12769781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer.
    Chang TH; Szabo E
    Cancer Res; 2000 Feb; 60(4):1129-38. PubMed ID: 10706135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of metallothionein in lung carcinoma: correlation with histological type and grade.
    Theocharis S; Karkantaris C; Philipides T; Agapitos E; Gika A; Margeli A; Kittas C; Koutselinis A
    Histopathology; 2002 Feb; 40(2):143-51. PubMed ID: 11952858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of inducible nitric oxide synthase and peroxisome proliferator-activated receptor gamma in non-small cell lung carcinoma.
    Lee TW; Chen GG; Xu H; Yip JH; Chak EC; Mok TS; Yim AP
    Eur J Cancer; 2003 Jun; 39(9):1296-301. PubMed ID: 12763220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC).
    Bren-Mattison Y; Van Putten V; Chan D; Winn R; Geraci MW; Nemenoff RA
    Oncogene; 2005 Feb; 24(8):1412-22. PubMed ID: 15608671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism].
    Zhang M; Zou P; Bai M; Tao XN; Jin Y; Guo R
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1169-72. PubMed ID: 12921638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased perioxisome proliferator-activated receptor gamma gene expression was correlated with poor prognosis in patients with lung cancer.
    Sasaki H; Tanahashi M; Yukiue H; Moiriyama S; Kobayashi Y; Nakashima Y; Kaji M; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
    Lung Cancer; 2002 Apr; 36(1):71-6. PubMed ID: 11891036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung.
    Chang TH; Szabo E
    Clin Cancer Res; 2002 Apr; 8(4):1206-12. PubMed ID: 11948134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of thalidomide on non-small cell lung cancer (NSCLC) cell lines: possible involvement in the PPARgamma pathway.
    DeCicco KL; Tanaka T; Andreola F; De Luca LM
    Carcinogenesis; 2004 Oct; 25(10):1805-12. PubMed ID: 15205358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis.
    Tsubouchi Y; Sano H; Kawahito Y; Mukai S; Yamada R; Kohno M; Inoue K; Hla T; Kondo M
    Biochem Biophys Res Commun; 2000 Apr; 270(2):400-5. PubMed ID: 10753637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible role of PPAR-γ and COX-2 receptor modulators in the treatment of Non-Small Cell lung carcinoma.
    Ravi Kiran Ammu VVV; Garikapati KK; Krishnamurthy PT; Chintamaneni PK; Pindiprolu SKSS
    Med Hypotheses; 2019 Mar; 124():98-100. PubMed ID: 30798928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists.
    Inoue K; Kawahito Y; Tsubouchi Y; Kohno M; Yoshimura R; Yoshikawa T; Sano H
    Biochem Biophys Res Commun; 2001 Sep; 287(3):727-32. PubMed ID: 11563856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies.
    Gustafson KS; LiVolsi VA; Furth EE; Pasha TL; Putt ME; Baloch ZW
    Am J Clin Pathol; 2003 Aug; 120(2):175-81. PubMed ID: 12931546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.